Aadi Bioscience Inc’s recently made public that its EXECUTIVE CHAIRMAN Desai Neil unloaded Company’s shares for reported $26705.0 on Aug 02 ’24. In the deal valued at $1.41 per share,18,933 shares were sold. As a result of this transaction, Desai Neil now holds 1,217,195 shares worth roughly $1.97 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Desai Neil sold 15,415 shares, generating $23,055 in total proceeds. Upon selling the shares at $1.50, the EXECUTIVE CHAIRMAN now owns 1,236,128 shares.
Before that, Desai Neil sold 5,652 shares. Aadi Bioscience Inc shares valued at $7,595 were divested by the EXECUTIVE CHAIRMAN at a price of $1.34 per share. As a result of the transaction, Desai Neil now holds 1,211,543 shares, worth roughly $1.96 million.
H.C. Wainwright downgraded its Aadi Bioscience Inc [AADI] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid January with a ‘”a Buy”‘ rating. Cowen began covering AADI with “an Outperform” recommendation on October 01, 2021. Ladenburg Thalmann started covering the stock on September 14, 2021. It rated AADI as “a Buy”.
Price Performance Review of AADI
On Tuesday, Aadi Bioscience Inc [NASDAQ:AADI] saw its stock jump 3.85% to $1.62. Over the last five days, the stock has gained 15.71%. Aadi Bioscience Inc shares have fallen nearly -19.80% since the year began. Nevertheless, the stocks have fallen -72.21% over the past one year. While a 52-week high of $7.24 was reached on 03/04/24, a 52-week low of $1.21 was recorded on 08/08/24. SMA at 50 days reached $1.5246, while 200 days put it at $2.2715.
Levels Of Support And Resistance For AADI Stock
The 24-hour chart illustrates a support level at 1.5700, which if violated will result in even more drops to 1.5200. On the upside, there is a resistance level at 1.6500. A further resistance level may holdings at 1.6800. The Relative Strength Index (RSI) on the 14-day chart is 61.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1171, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 2.38%. Stochastics%K at 82.13% indicates the stock is a selling.
How much short interest is there in Aadi Bioscience Inc?
A steep rise in short interest was recorded in Aadi Bioscience Inc stocks on 2024-07-31, dropping by -0.56 million shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 0.75 million shares. There was a decline of -296.64%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 08, 2021 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $45 price target.
